Keros Therapeutics (KROS) Current Leases (2019 - 2025)
Keros Therapeutics posted quarterly Current Leases of $2.4 million for Q4 2025, up 21.74% year-on-year from $2.0 million in Q4 2024, and up 3.88% on a QoQ basis from $2.3 million in Q3 2025.
Keros Therapeutics (KROS) has 7 years of Current Leases data on file, last reported at $2.4 million in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 21.74% year-over-year to $2.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (up 21.74% YoY), and the FY2025 full-year result was $2.4 million, up 21.74% from the prior year.
- Current Leases for Q4 2025 stood at $2.4 million, up from $2.3 million in the prior quarter.
- Across five years, Current Leases topped out at $2.4 million in Q4 2025 and bottomed at $436000.0 in Q1 2021.
- The 5-year median for Current Leases is $944500.0 (2022), against an average of $1.2 million.
- The widest annual swing landed in 2022, when Current Leases slumped 47.22%; it then soared 203.93% in 2024.
- A 5-year view of Current Leases shows it stood at $862000.0 in 2021, then plunged by 47.22% to $455000.0 in 2022, then surged by 120.88% to $1.0 million in 2023, then jumped by 96.82% to $2.0 million in 2024, then advanced by 21.74% to $2.4 million in 2025.
- The last three Current Leases figures came in at $2.4 million (Q4 2025), $2.3 million (Q3 2025), and $2.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | 2.32 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 611,000.00 |
| Dec 31, 2022 | 455,000.00 |
| Sep 30, 2022 | 455,000.00 |
| Jun 30, 2022 | 670,000.00 |
| Mar 31, 2022 | 884,000.00 |
| Dec 31, 2021 | 862,000.00 |
| Sep 30, 2021 | 843,000.00 |
| Jun 30, 2021 | 449,000.00 |
| Mar 31, 2021 | 436,000.00 |
| Dec 31, 2020 | 423,000.00 |
| Sep 30, 2020 | 412,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Mar 31, 2020 | 388,000.00 |
| Dec 31, 2019 | 376,000.00 |